Business  /  Published 08.04.22

Lupin boosts portfolio

Lupin on Thursday said it has completed the acquisition of a portfolio of brands from Anglo-French Drugs and Industries Ltd (AFDIL) and its associates. Early this year, the pharmaceutical major had a...
By Our Special Correspondent in Mumbai

Business  /  Published 11.03.22

Lupin sets up lab in Bengal

The diagnostic arm of pharma major Lupin has set up a reference lab in Calcutta as a part of a nationwide expansion plan to be rolled out over the next five years. Lupin Diagnostics, a wholly owned s...
By A Staff Reporter in Calcutta

Business  /  Published 11.05.21

Eli Lilly in pact with trio for drug

Eli Lilly and Company on Monday said it has inked voluntary licensing agreements with three Indian pharmaceutical firms — Sun Pharma, Cipla and Lupin — to expedite the availability of its ...
By Our Special Correspondent in Mumbai

Business  /  Published 26.04.21

Drug recall in US

Leading generic drug makers Lupin, Sun Pharma and Jubilant Cadista are recalling different products in the US, the world’s largest market for medicines, for different reasons. According to the ...
By PTI in New Delhi

Entertainment  /  Published 17.02.21

‘Acting liberates me, acting completes me’

Season 2 of The Family Man may have been postponed to summer, but Manoj Bajpayee has reason to celebrate, having bagged the Best Actor honour for his performance in the film Bhonsle at the recent Crit...
By Priyanka Roy 


Entertainment  /  Published 29.01.21

Lupin is creating waves worldwide

A“gentleman burglar” has been quietly but quickly working his way up the Netflix charts. Ever since it dropped in early January, Lupin — a smart, contemporary twist on the French cla...
By Priyanka Roy 

Opinion  /  Published 13.11.20

Dark web: Cyber attacks on pharmaceuticals

Public health has been compromised by the pandemic. The health of pharmaceutical companies is under threat too, but from a different kind of source. The Indian pharmaceutical company, Lupin, is the la...
By The Editorial Board

Business  /  Published 24.12.18

Lupin in drug licence pact with US firm

Pharma major Lupin Ltd and the US-based AbbVie on Monday announced a partnership to develop and commercialise the former’s novel drug to treat hematological cancers.Under the pact, AbbVie, a biophar...
By Our Bureau in Mumbai

Business  /  Published 07.04.19

Lupin recalls birth control pills

By PTI in New Delhi

Business  /  Published 27.11.18

Lupin CFO Ramesh Swaminathan quits

Ramesh Swaminathan, chief financial officer (CFO) of Lupin, is stepping down from the pharmaceutical firm.On Tuesday, Lupin informed bourses that Swaminathan has decided to pursue responsibilities out...
By Our Special Correspondent in Mumbai


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.